Yang Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yang Chen has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Wenmin Tian
Center for Precision Medicine Multi-Omics Research, Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China
11 shared publications- Catherine C. L. Wong
Clinical Research Institute, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
5 shared publications Haohao Tang
Department of Biochemistry & Biophysics, School of Basic Medical Sciences, Institute of Advanced Clinical Medicine, Peking University, Beijing, China
5 shared publicationsHongli Wang
Center for Precision Medicine Multi-Omics Research, Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China
3 shared publications- Li Yu
School of Life Sciences, Tsinghua University, Beijing, China
3 shared publications - Wenmin Tian
Center for Precision Medicine Multi-Omics Research, Institute of Advanced Clinical Medicine, Peking University, Beijing 100191, China
3 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (8) , 879
Isolation and Characterization of Extracellular Vesicles from Human and Mouse Pancreatic Tissue
Extracellular Vesicles (EVs) have been increasingly recognized as mediators of intercellular communication in pancreatic tissues, carrying molecular cargo reflective of their cellular origin; however, their direct isolation from solid tissue remains technically challenging due to the high enzymatic activity, lipid content, and structural fragility of the pancreas. Here, we establish a pancreas-adapted and reproducible workflow for the isolation of EVs directly from human and mouse pancreatic tissues across tumor and non-tumorous contexts. This approach integrates controlled tissue processing, gentle enzymatic-mechanical dissociation, and sequential centrifugation to enable efficient vesicle recovery while preserving structural integrity and minimizing contamination. The isolated EVs exhibited characteristic size distributions, intact morphology, and enrichment of canonical EV markers, accompanied by depletion of intracellular components. Quantitative analyses demonstrated high reproducibility across independent isolations, with a coefficient of variation of less than 6%. Proteomic profiling revealed selective enrichment of vesicle-associated proteins and preservation of molecular differences between tumor and normal pancreatic tissues, indicating that tissue-derived EVs retain disease-associated protein signatures. Together, these results establish a standardized framework for pancreas-derived EV isolation that supports reproducible downstream analyses and facilitates molecular characterization of pancreatic tissues.
- 30 July 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (8) , 879
Open AccessIsolation and Characterization of Extracellular Vesicles from Human and Mouse Pancreatic Tissue
Extracellular Vesicles (EVs) have been increasingly recognized as mediators of intercellular communication in pancreatic tissues, carrying molecular cargo reflective of their cellular origin; however, their direct isolation from solid tissue remains technically challenging due to the high enzymatic activity, lipid content, and structural fragility of the pancreas. Here, we establish a pancreas-adapted and reproducible workflow for the isolation of EVs directly from human and mouse pancreatic tissues across tumor and non-tumorous contexts. This approach integrates controlled tissue processing, gentle enzymatic-mechanical dissociation, and sequential centrifugation to enable efficient vesicle recovery while preserving structural integrity and minimizing contamination. The isolated EVs exhibited characteristic size distributions, intact morphology, and enrichment of canonical EV markers, accompanied by depletion of intracellular components. Quantitative analyses demonstrated high reproducibility across independent isolations, with a coefficient of variation of less than 6%. Proteomic profiling revealed selective enrichment of vesicle-associated proteins and preservation of molecular differences between tumor and normal pancreatic tissues, indicating that tissue-derived EVs retain disease-associated protein signatures. Together, these results establish a standardized framework for pancreas-derived EV isolation that supports reproducible downstream analyses and facilitates molecular characterization of pancreatic tissues.
- Open Access
- 11 June 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (6) , 678
A Micro-Quantitative and FFPE-Compatible Workflow for Immunohistochemistry-Guided Spatial Proteomic Analysis of Cellular Subpopulations Within the Tumor Microenvironment
Understanding the spatial proteomic landscape of human tumors is essential for dissecting cellular heterogeneity and microenvironmental interactions in cancer biology. Traditional bulk proteomic approaches, however, obscure spatial information and average out signals from distinct cell populations. Here, we present a detailed and reproducible micro-quantitative protocol for spatially resolved proteomic analysis of specific cellular subpopulations isolated from immunohistochemistry (IHC)-labeled formalin-fixed paraffin-embedded (FFPE) tissue sections using laser microdissection (LMD). By combining IHC staining to visually define phenotypically distinct cells within preserved tissue architecture and precise LMD capture, approximately 6000 target cells can be isolated per sample for downstream proteomic quantification. Despite the ultra-low input, optimized lysis and digestion steps ensure consistent peptide recovery and highly reproducible label-free LC–MS/MS data across replicates. Integrating immunohistochemistry staining-guided spatial sampling with ultrasensitive quantitative proteomics, this workflow enables reliable cell-type-specific profiling directly within human tumor tissues. The protocol bridges histopathology and proteomics, offering a practical framework for translational research exploring spatial protein signatures and tumor microenvironmental heterogeneity.
- 11 June 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (6) , 678
Open AccessA Micro-Quantitative and FFPE-Compatible Workflow for Immunohistochemistry-Guided Spatial Proteomic Analysis of Cellular Subpopulations Within the Tumor Microenvironment
Understanding the spatial proteomic landscape of human tumors is essential for dissecting cellular heterogeneity and microenvironmental interactions in cancer biology. Traditional bulk proteomic approaches, however, obscure spatial information and average out signals from distinct cell populations. Here, we present a detailed and reproducible micro-quantitative protocol for spatially resolved proteomic analysis of specific cellular subpopulations isolated from immunohistochemistry (IHC)-labeled formalin-fixed paraffin-embedded (FFPE) tissue sections using laser microdissection (LMD). By combining IHC staining to visually define phenotypically distinct cells within preserved tissue architecture and precise LMD capture, approximately 6000 target cells can be isolated per sample for downstream proteomic quantification. Despite the ultra-low input, optimized lysis and digestion steps ensure consistent peptide recovery and highly reproducible label-free LC–MS/MS data across replicates. Integrating immunohistochemistry staining-guided spatial sampling with ultrasensitive quantitative proteomics, this workflow enables reliable cell-type-specific profiling directly within human tumor tissues. The protocol bridges histopathology and proteomics, offering a practical framework for translational research exploring spatial protein signatures and tumor microenvironmental heterogeneity.
- Open Access
- 8 November 2025
- Published by Elsevier in Journal of Proteomics
- Vol. 323, 105556
Corrigendum to “Serum proteomics identifies biomarkers for predicting non-survivors in elderly COVID-19 patients” [Journal of Proteomics, volume 311 (2025) 105356].
- 8 November 2025
- Published by Elsevier in Journal of Proteomics
- Vol. 323, 105556
Open AccessCorrigendum to “Serum proteomics identifies biomarkers for predicting non-survivors in elderly COVID-19 patients” [Journal of Proteomics, volume 311 (2025) 105356].
- 10 October 2025
- Published by Springer Nature in Science China Life Sciences
- Vol. 69 (4) , 1117-1120
Toward a comprehensive map of Rab-mediated cargo transport to migrasomes
- 10 October 2025
- Published by Springer Nature in Science China Life Sciences
- Vol. 69 (4) , 1117-1120
Toward a comprehensive map of Rab-mediated cargo transport to migrasomes
- 23 August 2025
- Published by Elsevier in Science Bulletin
- Vol. 71 (4) , 717-721
Migrion: a Migrasome-mediated unit for intercellular viral transmission
- 23 August 2025
- Published by Elsevier in Science Bulletin
- Vol. 71 (4) , 717-721
Migrion: a Migrasome-mediated unit for intercellular viral transmission
- 18 July 2025
- Published by Springer Nature in Science China Life Sciences
- Vol. 69 (4) , 1057-1066
A decade of discovery: tracing the footmarks of migrasomes, unveiling the footprints of cells
The study of migrasomes, a newly discovered cellular structure, holds great potential for uncovering unknown cellular and molecular mechanisms in intercellular communication and disease processes. Migrasomes, with diameters ranging from 500 nm to 3 µm, form at the cell tail during migration and are subsequently released extracellularly. Their biogenesis involves site determination, membrane swelling and expansion. Migrasomes contain a diverse array of constituents, including nucleic acids, proteins, lipids, nanovesicles, viral particles, and organelles. Migrasomes offer a window into understanding the altered cellular or tissue states, providing novel mechanisms for understanding their physiological and pathological processes. Migrasome detection holds promise for diagnostic applications. The interdisciplinary nature of migrasome research highlights the need for continued integration of cutting-edge technologies, such as multi-omics, advanced microscopy, and bioengineering, to fully explore their biological significance and therapeutic potential.
- 18 July 2025
- Published by Springer Nature in Science China Life Sciences
- Vol. 69 (4) , 1057-1066
A decade of discovery: tracing the footmarks of migrasomes, unveiling the footprints of cells
The study of migrasomes, a newly discovered cellular structure, holds great potential for uncovering unknown cellular and molecular mechanisms in intercellular communication and disease processes. Migrasomes, with diameters ranging from 500 nm to 3 µm, form at the cell tail during migration and are subsequently released extracellularly. Their biogenesis involves site determination, membrane swelling and expansion. Migrasomes contain a diverse array of constituents, including nucleic acids, proteins, lipids, nanovesicles, viral particles, and organelles. Migrasomes offer a window into understanding the altered cellular or tissue states, providing novel mechanisms for understanding their physiological and pathological processes. Migrasome detection holds promise for diagnostic applications. The interdisciplinary nature of migrasome research highlights the need for continued integration of cutting-edge technologies, such as multi-omics, advanced microscopy, and bioengineering, to fully explore their biological significance and therapeutic potential.
- Open Access
- 5 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
β-propeller protein-associated neurodegeneration protein WDR45 regulates stress granule disassembly via phase separation with Caprin-1
β-propeller protein-associated neurodegeneration (BPAN) is a rare X-linked neurodegenerative disorder caused by mutations in the WDR45 gene, yet its molecular mechanisms remain poorly understood. Here, we identify a role for WDR45 in stress granule (SG) disassembly, mediated through its phase separation with Caprin-1. We demonstrate that WDR45 forms gel-like condensates via its WD5 domain, which competitively displaces G3BP1 from Caprin-1 to promote SG disassembly. BPAN-associated WDR45 mutations impair condensate formation and Caprin-1 interaction, leading to delayed SG disassembly, which correlates with earlier disease onset. WDR45 depletion also exacerbates amyotrophic lateral sclerosis-associated pathological SGs, highlighting its broader relevance to neurodegenerative diseases. Using iPSC-derived midbrain neurons from a BPAN patient, we demonstrate delayed SG recovery, directly linking WDR45 dysfunction to neurodegeneration. These findings establish WDR45 as a critical regulator of SG dynamics, uncover a potential molecular basis of BPAN pathogenesis, and identify therapeutic targets for neurodegenerative diseases associated with SG dysregulation.
- 5 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open Accessβ-propeller protein-associated neurodegeneration protein WDR45 regulates stress granule disassembly via phase separation with Caprin-1
β-propeller protein-associated neurodegeneration (BPAN) is a rare X-linked neurodegenerative disorder caused by mutations in the WDR45 gene, yet its molecular mechanisms remain poorly understood. Here, we identify a role for WDR45 in stress granule (SG) disassembly, mediated through its phase separation with Caprin-1. We demonstrate that WDR45 forms gel-like condensates via its WD5 domain, which competitively displaces G3BP1 from Caprin-1 to promote SG disassembly. BPAN-associated WDR45 mutations impair condensate formation and Caprin-1 interaction, leading to delayed SG disassembly, which correlates with earlier disease onset. WDR45 depletion also exacerbates amyotrophic lateral sclerosis-associated pathological SGs, highlighting its broader relevance to neurodegenerative diseases. Using iPSC-derived midbrain neurons from a BPAN patient, we demonstrate delayed SG recovery, directly linking WDR45 dysfunction to neurodegeneration. These findings establish WDR45 as a critical regulator of SG dynamics, uncover a potential molecular basis of BPAN pathogenesis, and identify therapeutic targets for neurodegenerative diseases associated with SG dysregulation.
- Open Access
- 9 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Deacetylated SNAP47 recruits HOPS to facilitate autophagosome-lysosome fusion independent of STX17
Autophagy, a conserved catabolic process implicated in a diverse array of human diseases, requires efficient fusion between autophagosomes and lysosomes to function effectively. Recently, SNAP47 has been identified as a key component of the dual-purpose SNARE complex mediating autophagosome-lysosome fusion in both bulk and selective autophagy. However, the spatiotemporal regulatory mechanisms of this SNARE complex remain unknown. In this study, we found that SNAP47 undergoes acetylation followed by deacetylation during bulk autophagy and mitophagy. The acetylation status of SNAP47 is regulated by the acetyltransferase CBP and the deacetylase HDAC2. Notably, the spatiotemporal regulatory dynamics of SNAP47 acetylation differ between bulk autophagy and mitophagy due to distinct regulation on the activity of acetyltransferase and deacetylase. Acetylated SNAP47 inhibits autophagosome-lysosome fusion by indirectly impeding SNARE complex assembly. Mechanistically, deacetylated SNAP47 recruits HOPS components to autophagic vacuoles independently of STX17 and STX17-SNAP47 interaction, while acetylated SNAP47 inhibits this recruitment, consequently leading to the failure of SNARE complex assembly. Taken together, our study uncovers a SNAP47 acetylation-dependent regulatory mechanism governing autophagosome-lysosome fusion by modulating the recruitment of HOPS to autophagic vacuoles without involving STX17, SNAP47-STX17 interaction and ternary SNARE complex formation.
- 9 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessDeacetylated SNAP47 recruits HOPS to facilitate autophagosome-lysosome fusion independent of STX17
Autophagy, a conserved catabolic process implicated in a diverse array of human diseases, requires efficient fusion between autophagosomes and lysosomes to function effectively. Recently, SNAP47 has been identified as a key component of the dual-purpose SNARE complex mediating autophagosome-lysosome fusion in both bulk and selective autophagy. However, the spatiotemporal regulatory mechanisms of this SNARE complex remain unknown. In this study, we found that SNAP47 undergoes acetylation followed by deacetylation during bulk autophagy and mitophagy. The acetylation status of SNAP47 is regulated by the acetyltransferase CBP and the deacetylase HDAC2. Notably, the spatiotemporal regulatory dynamics of SNAP47 acetylation differ between bulk autophagy and mitophagy due to distinct regulation on the activity of acetyltransferase and deacetylase. Acetylated SNAP47 inhibits autophagosome-lysosome fusion by indirectly impeding SNARE complex assembly. Mechanistically, deacetylated SNAP47 recruits HOPS components to autophagic vacuoles independently of STX17 and STX17-SNAP47 interaction, while acetylated SNAP47 inhibits this recruitment, consequently leading to the failure of SNARE complex assembly. Taken together, our study uncovers a SNAP47 acetylation-dependent regulatory mechanism governing autophagosome-lysosome fusion by modulating the recruitment of HOPS to autophagic vacuoles without involving STX17, SNAP47-STX17 interaction and ternary SNARE complex formation.
- Open Access
- 16 December 2024
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (2) , 750-761
Deep Saliva Proteomics Elucidating the Pathogenesis of Early Childhood Caries and Identifying Biomarkers for Early Prediction
Early childhood caries (ECC) significantly impacts the physical and mental health of children. Saliva stands as a critical model for investigating the pathogenesis of caries disease since it reflects both host and microbial dynamics. However, the specific contributions of salivary host factors to ECC have not been fully understood. In this study, we monitored a prospective cohort of 3-4 year-old healthy children for 12 months, who either stayed caries-free or developed caries. Deep quantitative proteomics analysis of saliva was conducted at both recruitment and end point of the cohort to investigate the molecular mechanisms underlying ECC etiology and identify potential biomarkers for caries prediction. Proteomics analysis identified a total of 2873 proteins and revealed involvement of immune response, dental structure repair, and regeneration, as well as interactions with microorganisms during caries pathogenesis. Characteristic salivary proteins were identified in caries-susceptible children prior to caries development. An ECC prediction panel of proteins keratin 3 (KRT3) and mucin 21 (MUC21) was established and further validated through another independent cohort. This study illuminated the role of the complex salivary microenvironment in caries etiology and offered a prognostic tool for early ECC prediction, thus facilitating the precise prevention and control of ECC to ultimately reduce its incidence.
- 16 December 2024
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (2) , 750-761
Open AccessDeep Saliva Proteomics Elucidating the Pathogenesis of Early Childhood Caries and Identifying Biomarkers for Early Prediction
Early childhood caries (ECC) significantly impacts the physical and mental health of children. Saliva stands as a critical model for investigating the pathogenesis of caries disease since it reflects both host and microbial dynamics. However, the specific contributions of salivary host factors to ECC have not been fully understood. In this study, we monitored a prospective cohort of 3-4 year-old healthy children for 12 months, who either stayed caries-free or developed caries. Deep quantitative proteomics analysis of saliva was conducted at both recruitment and end point of the cohort to investigate the molecular mechanisms underlying ECC etiology and identify potential biomarkers for caries prediction. Proteomics analysis identified a total of 2873 proteins and revealed involvement of immune response, dental structure repair, and regeneration, as well as interactions with microorganisms during caries pathogenesis. Characteristic salivary proteins were identified in caries-susceptible children prior to caries development. An ECC prediction panel of proteins keratin 3 (KRT3) and mucin 21 (MUC21) was established and further validated through another independent cohort. This study illuminated the role of the complex salivary microenvironment in caries etiology and offered a prognostic tool for early ECC prediction, thus facilitating the precise prevention and control of ECC to ultimately reduce its incidence.
- Open Access
- 26 November 2024
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (11) , e70058
Indeterminate Result of Interferon‐γ Release Assay—A Risk Factor of Mortality for COVID‐19 and Non‐COVID‐19 Respiratory Infections
Toward the end of 2022, the cessation of China's “dynamic zero‐COVID policy” had led to a notable outbreak of SARS‐CoV‐2 infections and a substantial number of severe cases and deaths were reported, which raised serious concerns. Concurrently, our study identified a significant increase in the incidence of indeterminate results from the Interferon‐γ Release Assay (IGRA) among hospitalized patients during this period. Peripheral T cells from these individuals were unable to produce measurable levels of IFN‐γ upon stimulation with the PHA mitogen. This indeterminate IGRA results emerged as a potential risk factor for increased mortality among severely affected elderly COVID‐19 patients, contributing to an understanding of the observed excess mortality. The deep serum proteomic analysis elucidated a dysfunctional immune response and defect in cardiac function of those patients. A predictive panel including IGRA results significantly enhanced the accuracy of predicting mortality outcomes in COVID‐19 cases (AUC = 0.9762). We also extended the relevance of indeterminate IGRA outcomes as a risk factor for mortality to elderly non‐COVID‐19 respiratory infections, providing valuable prognostic insights into this type of disease and informing targeted and effective therapeutic interventions for similar outbreaks in the future.
- 26 November 2024
- Published by Wiley in Journal of Medical Virology
- Vol. 96 (11) , e70058
Open AccessIndeterminate Result of Interferon‐γ Release Assay—A Risk Factor of Mortality for COVID‐19 and Non‐COVID‐19 Respiratory Infections
Toward the end of 2022, the cessation of China's “dynamic zero‐COVID policy” had led to a notable outbreak of SARS‐CoV‐2 infections and a substantial number of severe cases and deaths were reported, which raised serious concerns. Concurrently, our study identified a significant increase in the incidence of indeterminate results from the Interferon‐γ Release Assay (IGRA) among hospitalized patients during this period. Peripheral T cells from these individuals were unable to produce measurable levels of IFN‐γ upon stimulation with the PHA mitogen. This indeterminate IGRA results emerged as a potential risk factor for increased mortality among severely affected elderly COVID‐19 patients, contributing to an understanding of the observed excess mortality. The deep serum proteomic analysis elucidated a dysfunctional immune response and defect in cardiac function of those patients. A predictive panel including IGRA results significantly enhanced the accuracy of predicting mortality outcomes in COVID‐19 cases (AUC = 0.9762). We also extended the relevance of indeterminate IGRA outcomes as a risk factor for mortality to elderly non‐COVID‐19 respiratory infections, providing valuable prognostic insights into this type of disease and informing targeted and effective therapeutic interventions for similar outbreaks in the future.